| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 157, Issue 3 1219-1225, Copyright © 1996 by American Association of Immunologists
ARTICLES |
V Patella, G de Crescenzo, I Marino, A Genovese, M Adt, GJ Gleich and G Marone
Division of Clinical Immunology, University of Naples Federico II, School of Medicine, Naples, Italy.
Eosinophilia in humans is often associated with heart disease and cardiac localization of eosinophil granule proteins, and several results suggest that granule proteins mediate endomyocardial damage. Here we investigated the in vitro effects of the four principal eosinophil granule proteins (eosinophil cationic protein (ECP), major basic protein (MBP), eosinophil-derived neurotoxin, and eosinophil peroxidase (EPO)) on the activation of effector cells of inflammation (mast cells) isolated from human heart tissue (HHMC). ECP and, to a lesser extent, MBP (0.3-3 microM), but not eosinophil-derived neurotoxin and eosinophil peroxidase stimulated the release of preformed (histamine and tryptase) and the de novo synthesis of vasoactive and proinflammatory mediators (PGD2) from HHMC. Activation of HHMC by ECP and MBP was Ca2+- and temperature-dependent and was abolished by preincubation (15 min, 37 degrees C) with 2-deoxy-D- glucose (10 mM) and antimycin A (1 microM). There was a significant correlation between the maximal percentage of histamine release induced by ECP and anti-IgE from HHMC (rs = 0.73; p < 0.005), by MBP and anti- IgE (rs = 0.79; p < 0.001), and by ECP and MBP (rs = 0.65; p < 0.005). A positive correlation was also found between histamine and tryptase secretion (rs = 0.71; p < 0.001) and between histamine and PGD2 release induced by ECP from HHMC (rs = 0.85; p < 0.001). This is the first demonstration that some eosinophil cationic proteins, namely ECP and MBP, found at the site of heart damage in patients with eosinophilia, act as complete secretagogues on HHMC. This observation indicates another mechanism by which infiltrating eosinophils and their metabolic products cause inflammatory reactions and thus endomyocardial lesions in patients with eosinophilia.
This article has been cited by other articles:
|
|
 |
|
  J. Zaky, C. Caraang, R. Yu, and A. El-Bialy Elevated Troponins and the Churg-Strauss Syndrome: A Case Report Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2005; 10(2): 131 - 136. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Afanasyeva, D. Georgakopoulos, D. F. Belardi, A. C. Ramsundar, J. G. Barin, D. A. Kass, and N. R. Rose Quantitative Analysis of Myocardial Inflammation by Flow Cytometry in Murine Autoimmune Myocarditis: Correlation with Cardiac Function Am. J. Pathol., March 1, 2004; 164(3): 807 - 815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. D. Klion, P. Noel, C. Akin, M. A. Law, D. G. Gilliland, J. Cools, D. D. Metcalfe, and T. B. Nutman Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness Blood, June 15, 2003; 101(12): 4660 - 4666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Piliponsky, G. J. Gleich, A. Nagler, I. Bar, and F. Levi-Schaffer Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor Blood, March 1, 2003; 101(5): 1898 - 1904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nakajima, K. Matsumoto, H. Suto, K. Tanaka, M. Ebisawa, H. Tomita, K. Yuki, T. Katsunuma, A. Akasawa, R. Hashida, et al. Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells Blood, August 15, 2001; 98(4): 1127 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Afanasyeva, Y. Wang, Z. Kaya, S. Park, M. J. Zilliox, B. H. Schofield, S. L. Hill, and N. R. Rose Experimental Autoimmune Myocarditis in A/J mice Is an Interleukin-4-Dependent Disease with a Th2 Phenotype Am. J. Pathol., July 1, 2001; 159(1): 193 - 203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Genovese, J.-P. Bouvet, G. Florio, B. Lamparter-Schummert, L. Bjorck, and G. Marone Bacterial Immunoglobulin Superantigen Proteins A and L Activate Human Heart Mast Cells by Interacting with Immunoglobulin E Infect. Immun., October 1, 2000; 68(10): 5517 - 5524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Davey and D. G Lalloo Drug induced chest pain---rare but important Postgrad. Med. J., July 1, 2000; 76(897): 420 - 422. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. Yoshida, T. Fukuda, M. Hatano, H. Koseki, S.-i. Okabe, K. Ishibashi, S. Kojima, M. Arima, I. Komuro, G. Ishii, et al. The role of Bcl6 in mature cardiac myocytes Cardiovasc Res, June 1, 1999; 42(3): 670 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Patella, I. Marino, E. Arbustini, B. Lamparter-Schummert, L. Verga, M. Adt, and G. Marone Stem Cell Factor in Mast Cells and Increased Mast Cell Density in Idiopathic and Ischemic Cardiomyopathy Circulation, March 17, 1998; 97(10): 971 - 978. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
